Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7WYL

Structure of the EV71 3Cpro with 337 inhibitor

Summary for 7WYL
Entry DOI10.2210/pdb7wyl/pdb
Descriptor3C protein, N-methyl-N-[[4-(trifluoromethyl)-1,3-thiazol-2-yl]methyl]prop-2-enamide (3 entities in total)
Functional Keywordsstructure of the ev71 3cpro with 337 inhibitor, viral protein
Biological sourceEnterovirus A71
Total number of polymer chains2
Total formula weight41293.26
Authors
Qin, B.,Hou, P.,Gao, X.,Cui, S. (deposition date: 2022-02-16, release date: 2022-06-22, Last modification date: 2023-11-29)
Primary citationQin, B.,Craven, G.B.,Hou, P.,Chesti, J.,Lu, X.,Child, E.S.,Morgan, R.M.L.,Niu, W.,Zhao, L.,Armstrong, A.,Mann, D.J.,Cui, S.
Acrylamide fragment inhibitors that induce unprecedented conformational distortions in enterovirus 71 3C and SARS-CoV-2 main protease.
Acta Pharm Sin B, 12:3924-3933, 2022
Cited by
PubMed: 35702321
DOI: 10.1016/j.apsb.2022.06.002
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.31 Å)
Structure validation

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon